Skip to content
10-Q

Quarterly Report

REMEDENT, INC.

0001144204-17-059067

← back to feed
Filed
Nov 14, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Nov 14, 2017 20M sh
Stockholders Equity Q2 2018 · Sep 30, 2017 $3.24M
Stockholders Equity Q2 2018 · Mar 31, 2017 $3.11M
Current Liabilities Q2 2018 · Sep 30, 2017 $1.65M
Current Liabilities Q2 2018 · Mar 31, 2017 $1.55M
Current Assets Q2 2018 · Sep 30, 2017 $1.39M
Current Assets Q2 2018 · Mar 31, 2017 $1.28M
Total Assets Q2 2018 · Sep 30, 2017 $4.97M
Total Assets Q2 2018 · Mar 31, 2017 $4.73M
Shares Diluted Q2 2018 · Sep 30, 2016 20M sh
Shares Diluted Q2 2018 · Sep 30, 2016 20M sh
Operating Cash Flow Q2 2018 · Sep 30, 2016 $18.13K
Cash And Equivalents Q2 2018 · Sep 30, 2016 $97.57K
Cash And Equivalents Q2 2018 · Mar 31, 2016 $94.43K
Eps Diluted Q2 2018 · Sep 30, 2016 $0.00
Eps Diluted Q2 2018 · Sep 30, 2016 $0.01
Eps Basic Q2 2018 · Sep 30, 2016 $0.00
Eps Basic Q2 2018 · Sep 30, 2016 $0.01
Sga Expense Q2 2018 · Sep 30, 2016 $308.88K
Sga Expense Q2 2018 · Sep 30, 2016 $527.8K
Rd Expense Q2 2018 · Sep 30, 2016 $0
Rd Expense Q2 2018 · Sep 30, 2016 $7.69K
Net Income Q2 2018 · Sep 30, 2016 $29.49K
Net Income Q2 2018 · Sep 30, 2016 $130.91K
Operating Income Q2 2018 · Sep 30, 2016 −$60.79K
Operating Income Q2 2018 · Sep 30, 2016 −$57.56K
Gross Profit Q2 2018 · Sep 30, 2016 $403.47K
Gross Profit Q2 2018 · Sep 30, 2016 $829.09K